Literature DB >> 15161645

Vascular apolipoprotein e expression and recruitment from circulation to modulate smooth muscle cell response to endothelial denudation.

Zachary W Q Moore1, Binghua Zhu, David G Kuhel, David Y Hui.   

Abstract

Apolipoprotein E (apoE) has been shown previously to have anti-proliferative and anti-migratory effects on smooth muscle cells in culture. In addition, overexpression of the apoE gene also reduces neointimal hyperplasia in mice after endothelial denudation. In this investigation, immunohistochemical techniques were used to demonstrate that apoE was present in the medial smooth muscle layers of the carotid artery between 1 and 28 days after endothelial cell denudation. Analysis of transgenic mice overexpressing human apoE in the liver revealed that apoE was recruited from the circulation to the injured site of the vessel wall. In situ hybridization using a mouse-specific apoE mRNA probe confirmed that apoE was also synthesized in the carotid artery after endothelial denudation. Interestingly, apoE accumulation in apoE transgenic mice followed a layer-specific pattern, and was inversely associated with smooth muscle alpha-actin expression. The vascular accumulation of apoE after endothelial denudation, and its association with alpha-actin-depleted smooth muscle cells, suggest that apoE inhibition of injury-induced neointimal hyperplasia is not due to the inhibition of injury-induced smooth muscle cell de-differentiation, but is likely a direct effect of apoE on smooth muscle cell migration and proliferation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15161645      PMCID: PMC1615764          DOI: 10.1016/S0002-9440(10)63769-8

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  25 in total

1.  Low levels of extrahepatic nonmacrophage ApoE inhibit atherosclerosis without correcting hypercholesterolemia in ApoE-deficient mice.

Authors:  F E Thorngate; L L Rudel; R L Walzem; D L Williams
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-08       Impact factor: 8.311

2.  Perlecan mediates the antiproliferative effect of apolipoprotein E on smooth muscle cells. An underlying mechanism for the modulation of smooth muscle cell growth?

Authors:  L Paka; I J Goldberg; J C Obunike; S Y Choi; U Saxena; I D Goldberg; S Pillarisetti
Journal:  J Biol Chem       Date:  1999-12-17       Impact factor: 5.157

Review 3.  Smooth muscle migration in atherosclerosis and restenosis.

Authors:  S M Schwartz
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

4.  Fibroblast growth factor 2 control of vascular tone.

Authors:  M Zhou; R L Sutliff; R J Paul; J N Lorenz; J B Hoying; C C Haudenschild; M Yin; J D Coffin; L Kong; E G Kranias; W Luo; G P Boivin; J J Duffy; S A Pawlowski; T Doetschman
Journal:  Nat Med       Date:  1998-02       Impact factor: 53.440

5.  Apolipoprotein E inhibits neointimal hyperplasia after arterial injury in mice.

Authors:  B Zhu; D G Kuhel; D P Witte; D Y Hui
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

6.  Both apolipoprotein E and immune deficiency exacerbate neointimal hyperplasia after vascular injury in mice.

Authors:  Binghua Zhu; Catherine A Reardon; Godfrey S Getz; David Y Hui
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-03-01       Impact factor: 8.311

7.  Apolipoprotein E inhibits serum-stimulated cell proliferation and enhances serum-independent cell proliferation.

Authors:  Y Y Ho; R J Deckelbaum; Y Chen; T Vogel; D A Talmage
Journal:  J Biol Chem       Date:  2001-09-10       Impact factor: 5.157

8.  Retroviral gene therapy in ApoE-deficient mice: ApoE expression in the artery wall reduces early foam cell lesion formation.

Authors:  A H Hasty; M F Linton; S J Brandt; V R Babaev; L A Gleaves; S Fazio
Journal:  Circulation       Date:  1999-05-18       Impact factor: 29.690

9.  Apolipoprotein E inhibits platelet-derived growth factor-induced vascular smooth muscle cell migration and proliferation by suppressing signal transduction and preventing cell entry to G1 phase.

Authors:  M Ishigami; D K Swertfeger; N A Granholm; D Y Hui
Journal:  J Biol Chem       Date:  1998-08-07       Impact factor: 5.157

10.  Distinction in genetic determinants for injury-induced neointimal hyperplasia and diet-induced atherosclerosis in inbred mice.

Authors:  David G Kuhel; Binghua Zhu; David P Witte; David Y Hui
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-06-01       Impact factor: 8.311

View more
  9 in total

Review 1.  Apolipoprotein E-induced cell signaling in the vessel wall.

Authors:  David Y Hui
Journal:  Rev Endocr Metab Disord       Date:  2004-12       Impact factor: 6.514

2.  Apolipoprotein E favours the blunting by high-fat diet of prostacyclin receptor activation in the mouse aorta.

Authors:  Yanhua Cheng; Paul M Vanhoutte; Susan W S Leung
Journal:  Br J Pharmacol       Date:  2018-07-22       Impact factor: 8.739

3.  Apolipoprotein E4 impairs macrophage efferocytosis and potentiates apoptosis by accelerating endoplasmic reticulum stress.

Authors:  James G Cash; David G Kuhel; Joshua E Basford; Anja Jaeschke; Tapan K Chatterjee; Neal L Weintraub; David Y Hui
Journal:  J Biol Chem       Date:  2012-06-23       Impact factor: 5.157

4.  Apolipoprotein E inhibits toll-like receptor (TLR)-3- and TLR-4-mediated macrophage activation through distinct mechanisms.

Authors:  Yanjuan Zhu; Ahmer Kodvawala; David Y Hui
Journal:  Biochem J       Date:  2010-04-28       Impact factor: 3.857

5.  Adipose tissue depot-specific differences in adipocyte apolipoprotein E expression.

Authors:  Zhi H Huang; Doris J Espiritu; Arlene Uy; Ai-Xuan Holterman; Joseph Vitello; Theodore Mazzone
Journal:  Metabolism       Date:  2011-06-12       Impact factor: 8.694

6.  apoE3[K146N/R147W] acts as a dominant negative apoE form that prevents remnant clearance and inhibits the biogenesis of HDL.

Authors:  Panagiotis Fotakis; Alexander Vezeridis; Ioannis Dafnis; Angeliki Chroni; Dimitris Kardassis; Vassilis I Zannis
Journal:  J Lipid Res       Date:  2014-04-28       Impact factor: 5.922

7.  Apolipoprotein E inhibition of vascular hyperplasia and neointima formation requires inducible nitric oxide synthase.

Authors:  Zachary W Q Moore; David Y Hui
Journal:  J Lipid Res       Date:  2005-08-01       Impact factor: 5.922

Review 8.  Intimal hyperplasia in murine models.

Authors:  David Y Hui
Journal:  Curr Drug Targets       Date:  2008-03       Impact factor: 3.465

Review 9.  Apolipoprotein E in Cardiometabolic and Neurological Health and Diseases.

Authors:  Jeyashree Alagarsamy; Anja Jaeschke; David Y Hui
Journal:  Int J Mol Sci       Date:  2022-08-31       Impact factor: 6.208

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.